한글목차

세계 디지털 처방전 시장 규모는 2024년에 23억 1,000만 달러에 달했습니다. 2033년에는 183억 9,000만 달러에 달할 것으로 예상되며, 2025년부터 2033년까지 예측 기간 동안 23.4%의 연평균 복합 성장률(CAGR)로 확대될 것으로 예상됩니다.

전자 처방전 시장으로도 알려진 세계 디지털 처방전 시장은 의료 처방전 작성, 관리, 보관, 전송을 위한 전자 시스템의 사용을 포괄합니다. 이러한 시스템은 전자 의료 기록(EHR) 및 약국 관리 시스템과 통합하여 처방전의 정확성을 높이고, 투약 오류를 최소화하며, 환자의 안전을 향상시키도록 설계되었습니다.

시장은 크게 솔루션과 서비스 두 가지로 분류됩니다. 솔루션에는 통합 시스템과 독립형 시스템이 있으며, 서비스에는 지원 및 유지보수, 도입, 네트워크 서비스, 교육, 훈련, 교육이 포함됩니다. 이 중 통합형 솔루션은 전자의무기록(EHR) 및 병원 관리 시스템과의 원활한 상호운용성을 통해 워크플로우의 효율성을 향상시킬 수 있어 압도적인 점유율을 차지하고 있습니다.

웹 및 클라우드 기반 솔루션은 확장성, 비용 효율성, 원격 접근성 등으로 인해 빠르게 성장하고 있습니다. 온프레미스 솔루션은 특히 데이터 보안과 규제 준수가 최우선 과제인 대규모 의료 기관에서 지속적으로 시장에서 강세를 보이고 있습니다.

전자 의료 기록(EHR) 솔루션의 채택 증가는 세계 디지털 처방전 시장의 성장을 크게 촉진하고 있으며, 예측 기간 동안 성장을 견인할 것으로 예상됩니다. 의료 서비스 제공업체가 의료 기록을 보다 효율적으로 관리할 수 있도록 돕습니다. 전자 처방 시스템과의 통합을 통해 처방의 정확성을 높이고, 투약 오류를 줄이며, 전체 워크플로우의 효율성을 높일 수 있습니다.

EHR은 전자처방전 시스템과 동기화되도록 설계되어 약력, 알레르기, 검사 결과 등 중요한 환자 데이터를 즉시 사용할 수 있도록 합니다. EHR과 디지털 처방 시스템의 상호운용성은 의사, 약사, 의료 기관 간의 치료 협력을 강화하여 전반적인 환자 안전과 치료 결과를 향상시킬 수 있도록 돕습니다. 치료 결과를 향상시킵니다.

데이터 보안 및 프라이버시 문제는 주로 관련 환자 정보의 기밀성 때문에 세계 디지털 처방전 시장의 성장을 저해할 것입니다. 디지털 처방전은 전자 데이터 전송에 크게 의존하기 때문에 잠재적인 데이터 유출, 무단 액세스 및 사이버 공격의 위험이 있습니다. 처방전에는 환자의 약력, 알레르기, 개인 건강 상태와 같은 민감한 정보가 포함되어 있습니다. 이러한 데이터를 전자적으로 저장하고 전송하는 것은 환자 정보의 기밀성과 무결성에 대한 우려를 불러일으킵니다.

의료 서비스 제공업체와 기술 기업은 미국의 HIPAA(Health Insurance Portability and Accountability Act), EU의 GDPR(EU 개인정보보호규정)과 같은 데이터 보호 규정을 준수해야 합니다. 준수해야 합니다. 이러한 법률은 환자 데이터를 보호하기 위해 엄격한 보안 조치를 요구하고 있으며, 이는 디지털 처방 플랫폼에 도전이 되고 비용이 많이 듭니다. 디지털 처방 시스템은 종종 전자 의료 기록(EHR) 및 기타 의료 IT 시스템과 통합되어야 하기 때문에 서로 다른 플랫폼 간의 데이터 보안을 보장하는 것은 복잡할 수 있습니다. 시스템 통합에 취약점이 있으면 환자 데이터가 무단 액세스에 노출될 수 있습니다. 따라서 위의 요인들이 세계 디지털 처방전 시장의 잠재적 성장을 제한할 수 있습니다.

세계의 디지털 처방전(Digital Prescription) 시장에 대해 조사했으며, 시장 개요와 함께 서비스 유형별/전달 모드별/지역별 동향, 경쟁 구도, 시장 진출 기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 시장 서론과 범위

제2장 주요 인사이트와 중요 포인트

제3장 시장 역학

• 영향요인
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
  • 영향 분석

제4장 전략적 인사이트와 업계 전망

• 시장 리더와 선구자
• CXO의 견해
• 최신 개발과 Break through
• 사례 연구/진행중인 조사
• 규제와 상환 상황
• Porter의 Five Forces 분석
• 공급망 분석
• 특허 분석
• SWOT 분석
• 미충족 요구와 갭
• 시장 진입 및 확장을 위한 추천 전략
• 시나리오 분석 베스트 케이스, 베이스 케이스, 워스트 케이스 예측
• 가격 분석과 가격 동향
• 주요 업계 리더

제5장 디지털 처방전 시장, 서비스 유형별

• 솔루션
• 서비스

제6장 디지털 처방전 시장, 전달 방법별

• 웹 및 클라우드 기반 솔루션
• 온프레미스

제7장 디지털 처방전 시장, 지역별 시장 분석과 성장 기회

• 북미
  • 미국
  • 캐나다
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 스페인
  • 이탈리아
  • 기타
• 라틴아메리카
  • 멕시코
  • 브라질
  • 아르헨티나
  • 기타
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 한국
  • 기타
• 중동 및 아프리카

제8장 경쟁 구도와 시장 포지셔닝

제9장 기업 개요

• Veradigm LLC
• Cerner Corporation(Oracle)
• DrFirst
• NXGN Management, LLC.
• MCKESSON CORPORATION
• Surescripts
• Athenahealth
• CNBC LLC.
• Practice Fusion, Inc.
• Networking Technology, Inc.

제10장 가정과 조사 방법

제11장 부록

영문목차

The global digital prescription market reached US$ 2.31 billion in 2024 and is expected to reach US$ 18.39 billion by 2033, growing at a CAGR of 23.4 % during the forecast period of 2025-2033.

The global digital prescription market, also known as the E-prescription market, encompasses the use of electronic systems to create, manage, store, and transmit medical prescriptions. These systems are designed to enhance prescription accuracy, minimize medication errors, and improve patient safety by integrating with electronic health records (EHRs) and pharmacy management systems.

The market is divided into two primary categories solutions and services. Solutions include integrated and standalone systems, while services encompass support & maintenance, implementation, network services, training, and education. Among these, integrated solutions dominate due to their seamless interoperability with electronic health records (EHRs) and hospital management systems, improving workflow efficiency.

Web & cloud-based solutions are experiencing rapid growth, driven by their scalability, cost-effectiveness, and remote accessibility. On-premise solutions continue to hold a strong market presence, particularly among large healthcare institutions, where data security and regulatory compliance are top priorities.

Market Dynamics: Drivers & Restraints

Increased adoption of electronic health record (EHR) Solutions

The increased adoption of electronic health record (EHR) solutions is significantly driving the growth of the global digital prescription market and is expected to drive it throughout the market forecast period.EHRs function as a centralized digital platform for storing, retrieving, and sharing patient data, allowing healthcare providers to manage medical records more efficiently. Their integration with e-prescription systems improves prescription accuracy, reduces medication errors, and enhances overall workflow efficiency.

EHRs are designed to work in sync with e-prescribing systems, ensuring that critical patient data, such as medication history, allergies, and lab results, is readily available. This real-time data accessibility helps reduce prescription errors and allows physicians to make more informed, data-driven prescribing decisions. The interoperability of EHR and e-prescription systems enhances care coordination between physicians, pharmacists, and healthcare institutions, improving overall patient safety and treatment outcomes.

Data Security and Privacy Concerns

Data security and privacy concerns will hinder the growth of the global digital prescription market, primarily due to the sensitivity of the patient information involved. Digital prescriptions rely heavily on electronic data transmission, which introduces risks of potential data breaches, unauthorized access, and cyberattacks. Prescriptions contain sensitive information, such as a patient's medication history, allergies, and personal health details. Storing and transmitting such data electronically creates concerns about the confidentiality and integrity of patient information.

Healthcare providers and technology companies must comply with data protection regulations, such as the Health Insurance Portability and Accountability Act (HIPAA) in the U.S. or the General Data Protection Regulation (GDPR) in the EU. These laws require stringent security measures to protect patient data, which can be challenging and costly for digital prescription platforms. As e-prescribing systems often need to integrate with Electronic Health Records (EHRs) and other healthcare IT systems, ensuring data security across different platforms can be complex. Any vulnerability in the system integration can expose patient data to unauthorized access. Thus, the above factors could be limiting the global digital prescription market's potential growth.

Segment Analysis

The global digital prescription market is segmented based on the type of services, delivery mode, and region.

Type of Services:

The services segment in type of services is expected to dominate the global digital prescription market with the highest market share

Services play a crucial role in the implementation, operation, and optimization of digital prescription systems. These services ensure that the technology is integrated efficiently, maintained properly, and used effectively by healthcare professionals. The main types of services offered in this market include support & maintenance, implementation, network services, and training & education.

Services include support & maintenance services, implementation services, network services, and training and education services. Implementation services focus on the deployment and integration of digital prescription systems within healthcare organizations, such as hospitals, clinics, and pharmacies. Network services support the connectivity and infrastructure necessary for real-time data exchange in digital prescription systems. These services ensure the secure transfer of prescriptions between healthcare providers, pharmacies, and other stakeholders. Training and education services ensure that healthcare professionals are well-equipped to use digital prescription systems effectively.

For instance, in September 2022, Ahmedabad-based JVS Technologies Pvt Ltd launched SoftClinic GenX, India's first zero-cost AI-powered digital prescription app. The app is designed to help doctors generate digital prescriptions within seconds and send them to patients via WhatsApp, Email, or SMS, eliminating the need for manual writing or typing. These factors have solidified the segment's position in the global digital prescription market.

Geographical Analysis

North America is expected to hold a significant position in the global digital prescription market with the highest market share

The North American digital prescription market is a rapidly growing segment of the healthcare industry, driven by various factors that promote the adoption of e-prescribing systems and digital prescription solutions. Regulatory support is one of the key factors propelling the growth of digital prescriptions in North America, particularly in the United States. The U.S. government has introduced various programs like Medicare and Medicaid incentives for the adoption of Electronic Health Records (EHRs) and e-prescribing solutions.

Continuous advancements in digital health technologies, including cloud computing, mobile applications, and artificial intelligence (AI), have significantly improved the functionality and efficiency of digital prescription systems. The integration of EHRs, telemedicine, and digital prescriptions enables healthcare providers to enhance clinical decision-making, reduce prescription errors, and provide better patient care. AI-powered systems further improve prescription accuracy and support real-time decision-making.

The adoption of digital prescriptions significantly reduces the risk of medication errors and fraud. By eliminating handwritten prescriptions, the chances of misinterpretation or illegibility are minimized, improving patient safety. E-prescribing systems also facilitate automatic checks for potential drug interactions, allergies, and contraindications, which improves prescription accuracy and prevents adverse drug events.

For instance, in August 2024, in New Jersey, Otsuka Precision Health, Inc. (OPH) and Click Therapeutics, Inc. officially launched Rejoyn, the first FDA-cleared prescription digital therapeutic (DTx) for major depressive disorder (MDD). Cleared in March 2024, Rejoyn is designed as an adjunct to clinician-managed outpatient care for adults (22+ years) who are already taking antidepressant medication. Thus, the above factors are consolidating the region's position as a dominant force in the global digital prescription market.

Competitive Landscape

The major global players in the digital prescription market include Veradigm LLC, Cerner Corporation (Oracle), DrFirst, NXGN Management, LLC., MCKESSON CORPORATION, Surescripts, Athenahealth, CNBC LLC., Practice Fusion, Inc., and Networking Technology, Inc., among others.

Key Developments

• In November 2024, Click Therapeutics launched software-enhanced drug therapies under its new click SE offering. This initiative aims to integrate clinically validated digital therapeutics with traditional pharmacotherapy, enhancing treatment efficacy and patient outcomes. The move aligns with evolving FDA guidance on Prescription Drug-Use Related Software (PDURS), which supports using software to provide clinically meaningful benefits beyond conventional drug therapies.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzed product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global digital prescription market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

• 1.1. Objectives of the Report
• 1.2. Report Coverage & Definitions
• 1.3. Report Scope

2. Executive Insights and Key Takeaways

• 2.1. Market Highlights and Strategic Takeaways
• 2.2. Key Trends and Future Projections
• 2.3. Snippet by Type of Services
• 2.4. Snippet by Delivery Mode
• 2.5. Snippet by Region

3. Dynamics

• 3.1. Impacting Factors
  • 3.1.1. Drivers
    • 3.1.1.1. Increased Adoption of Electronic Health Record (EHR) Solutions
    • 3.1.1.2. Rising Adoption of Cloud-Based Solutions
  • 3.1.2. Restraints
    • 3.1.2.1. Data Security and Privacy Concerns
    • 3.1.2.2. High Initial Investment Costs
  • 3.1.3. Opportunity
    • 3.1.3.1. Growing Adoption of Telemedicine
  • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

• 4.1. Market Leaders and Pioneers
  • 4.1.1. Emerging Pioneers and Prominent Players
  • 4.1.2. Established leaders with largest selling Brand
  • 4.1.3. Market leaders with established Product
• 4.2. CXO Perspectives
• 4.3. Latest Developments and Breakthroughs
• 4.4. Case Studies/Ongoing Research
• 4.5. Regulatory and Reimbursement Landscape
  • 4.5.1. North America
  • 4.5.2. Europe
  • 4.5.3. Asia Pacific
  • 4.5.4. Latin America
  • 4.5.5. Middle East & Africa
• 4.6. Porter's Five Forces Analysis
• 4.7. Supply Chain Analysis
• 4.8. Patent Analysis
• 4.9. SWOT Analysis
• 4.10. Unmet Needs and Gaps
• 4.11. Recommended Strategies for Market Entry and Expansion
• 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
• 4.13. Pricing Analysis and Price Dynamics
• 4.14. Key Opinion Leaders

5. Digital Prescription Market, By Type of Services

• 5.1. Introduction
  • 5.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type of Services
  • 5.1.2. Market Attractiveness Index By Type of Services
• 5.2. Solutions*
  • 5.2.1. Introduction
  • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.2.3. Integrated Solutions
  • 5.2.4. Standalone Solutions
• 5.3. Services
  • 5.3.1. Support & Maintenance Services
  • 5.3.2. Implementation Services
  • 5.3.3. Network Services
  • 5.3.4. Training And Education Services

6. Digital Prescription Market By Delivery Mode

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
  • 6.1.2. Market Attractiveness Index By Delivery Mode
• 6.2. Web and Cloud-Based Solutions*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. On Premise

7. Digital Prescription Market, By Regional Market Analysis and Growth Opportunities

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 7.1.2. Market Attractiveness Index, By Region
• 7.2. North America
  • 7.2.1. Introduction
  • 7.2.2. Key Region-Specific Dynamics
  • 7.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Services
  • 7.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
  • 7.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 7.2.5.1. U.S.
    • 7.2.5.2. Canada
• 7.3. Europe
  • 7.3.1. Introduction
  • 7.3.2. Key Region-Specific Dynamics
  • 7.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Services
  • 7.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
  • 7.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 7.3.5.1. Germany
    • 7.3.5.2. U.K.
    • 7.3.5.3. France
    • 7.3.5.4. Spain
    • 7.3.5.5. Italy
    • 7.3.5.6. Rest of Europe
• 7.4. Latin America
  • 7.4.1. Introduction
  • 7.4.2. Key Region-Specific Dynamics
  • 7.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Services
  • 7.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
  • 7.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 7.4.5.1. Mexico
    • 7.4.5.2. Brazil
    • 7.4.5.3. Argentina
    • 7.4.5.4. Rest of Latin America
• 7.5. Asia-Pacific
  • 7.5.1. Introduction
  • 7.5.2. Key Region-Specific Dynamics
  • 7.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Services
  • 7.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
  • 7.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 7.5.5.1. China
    • 7.5.5.2. India
    • 7.5.5.3. Japan
    • 7.5.5.4. South Korea
    • 7.5.5.5. Rest of Asia-Pacific
• 7.6. Middle East and Africa
  • 7.6.1. Introduction
  • 7.6.2. Key Region-Specific Dynamics
  • 7.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type of Services
  • 7.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode

8. Competitive Landscape and Market Positioning

• 8.1. Competitive Overview and Key Market Players
• 8.2. Market Share Analysis and Positioning Matrix
• 8.3. Strategic Partnerships, Mergers & Acquisitions
• 8.4. Key Developments in Product Portfolios and Innovations
• 8.5. Company Benchmarking

9. Company Profiles

• 9.1. Veradigm LLC*
  • 9.1.1. Company Overview
  • 9.1.2. Product Portfolio
    • 9.1.2.1. Product Description
    • 9.1.2.2. Product Key Performance Indicators (KPIs)
    • 9.1.2.3. Historic and Forecasted Product Sales
    • 9.1.2.4. Product Sales Volume
  • 9.1.3. Financial Overview
    • 9.1.3.1. Company Revenue's
    • 9.1.3.2. Geographical Revenue Shares
    • 9.1.3.3. Revenue Forecasts
  • 9.1.4. Key Developments
    • 9.1.4.1. Mergers & Acquisitions
    • 9.1.4.2. Key Product Development Activities
    • 9.1.4.3. Regulatory Approvals, etc.
  • 9.1.5. SWOT Analysis
• 9.2. Cerner Corporation (Oracle)
• 9.3. DrFirst
• 9.4. NXGN Management, LLC.
• 9.5. MCKESSON CORPORATION
• 9.6. Surescripts
• 9.7. Athenahealth
• 9.8. CNBC LLC.
• 9.9. Practice Fusion, Inc.
• 9.10. Networking Technology, Inc.

LIST NOT EXHAUSTIVE

10. Assumption and Research Methodology

• 10.1. Data Collection Methods
• 10.2. Data Triangulation
• 10.3. Forecasting Techniques
• 10.4. Data Verification and Validation

11. Appendix

• 11.1. About Us and Services
• 11.2. Contact Us